Ligand ID: 0U9 Drugbank ID: DB01128(Bicalutamide) Indication:For treatment (together with surgery or LHRH analogue) of advanced prostatic cancer. |
DrReposER ID / Desc. | Hit PDBID |
Hit Macromolecule |
Res. Matches |
View | Interface | RMSD | Seq. Identity (%) |
HETATM | Dock | |
---|---|---|---|---|---|---|---|---|---|---|
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6lxt | SPIKE PROTEIN S2 (SARS-CoV-2) | 5 / 12 | LEU B 948ALA A 944THR A 941ALA B 944THR B 941 | 1.39A | 15.03 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m3m | NUCLEOCAPSID PROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 67LEU A 160TRP A 109ALA A 174THR A 58 | 1.52A | 17.95 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 674VAL A 667ARG A 457ALA A 558THR A 556 | 1.43A | 19.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP8 (SARS-CoV-2) | 5 / 12 | TYR B 138LEU B 169VAL B 186ALA B 188THR B 146 | 1.79A | 19.32 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6m71 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 530LEU A 527VAL A 373ARG A 654ALA A 376 | 1.76A | 19.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vsb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE A 802TYR C 707VAL C 705ALA A 893THR A 887 | 1.47A | 16.90 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vxx | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE B 802TYR A 707VAL A 705ALA B 893THR B 887 | 1.52A | 15.85 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6vyb | SPIKE GLYCOPROTEIN (SARS-CoV-2) | 5 / 12 | PHE C 802TYR B 707VAL B 705ALA C 893THR C 887 | 1.49A | 15.85 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR B 56LEU B 80ALA B 131GLU B 67ALA B 68 | 1.78A | 20.83 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR C 264ARG C 166ALA C 114GLU C 167THR C 168 | 1.40A | 20.83 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6w9c | PAPAIN-LIKEPROTEINASE (SARS-CoV-2) | 5 / 12 | TYR A 56VAL A 11ALA A 68THR A 74ALA A 131 | 1.71A | 20.83 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wiq | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 56VAL A 53ALA B 150ALA B 110 | 1.70A | 16.18 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU B 73VAL B 70ALA B 95ALA B 81THR B 84 | 1.69A | 23.29 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wlc | URIDYLATE-SPECIFICENDORIBONUCLEASE (SARS-CoV-2) | 5 / 12 | LEU A 73VAL A 70ALA A 95ALA A 81THR A 84 | 1.68A | 23.29 | NoneEDO A 408 (-4.0A)NoneNoneNone | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.69A | 16.18 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wqd | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 56VAL A 53ALA B 150ALA B 110 | 1.71A | 16.18 | NoneNoneEDO B 302 ( 4.8A)EDO B 302 (-3.7A)None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 5 / 12 | TYR A 56VAL A 11ALA A 68THR A 74ALA A 131 | 1.73A | 19.96 | None CL A 506 (-3.7A)NoneNoneNone | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6wrh | PEPTIDASE C16 (SARS-CoV-2) | 6 / 12 | TYR A 56LEU A 80PHE A 79ALA A 131GLU A 67ALA A 68 | 1.76A | 19.96 | NoneNoneNoneNone CL A 506 (-3.5A)None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.74A | 14.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | PHE B 92LEU A 56VAL A 53ALA B 150ALA B 110 | 1.75A | 14.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6yhu | REPLICASEPOLYPROTEIN 1A (SARS-CoV-2) | 5 / 12 | LEU D 128VAL D 130THR D 141ALA D 152THR D 148 | 1.78A | 14.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | TYR A 54LEU A 57THR A 24GLU A 47THR A 45 | 1.71A | 21.89 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 6ynq | REPLICASEPOLYPROTEIN 1AB (SARS-CoV-2) | 5 / 12 | TYR A 54LEU A 57THR A 25GLU A 47THR A 45 | 1.76A | 21.89 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.52A | 19.32 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7btf | NSP12 (SARS-CoV-2) | 5 / 12 | LEU A 240PHE A 45ARG A 733ALA A 125THR A 206 | 1.79A | 19.77 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 530LEU A 527ALA A 376THR A 538GLU A 658 | 1.64A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP12NSP8 (SARS-CoV-2) | 5 / 12 | VAL A 398ARG B 190ALA A 382ALA B 125THR B 124 | 1.70A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP7NSP8 (SARS-CoV-2) | 5 / 12 | PHE D 92LEU C 56VAL C 53ALA D 150ALA D 110 | 1.60A | 18.34 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv1 | NSP8 (SARS-CoV-2) | 5 / 12 | TYR B 138LEU B 169VAL B 186ALA B 188THR B 146 | 1.78A | 18.34 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 674VAL A 667ARG A 457ALA A 558THR A 556 | 1.49A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP12 (SARS-CoV-2) | 5 / 12 | TYR A 748PHE A 753ALA A 699THR A 701ALA A 706 | 1.79A | 19.69 | None | ||
![]() | 4FIA_A_0U9A601_1 (CHOLESTEROL24-HYDROXYLASE) | 7bv2 | NSP8 (SARS-CoV-2) | 5 / 12 | TYR B 138LEU B 169VAL B 186ALA B 188THR B 146 | 1.76A | 18.34 | None |